ВЛИЯНИЕ ДЕКСАМЕТАЗОНА НА ИНТЕРФЕРОН-α- ИНДУЦИРОВАННУЮ ДИФФЕРЕНЦИРОВКУ МОНОЦИТОВ В ДЕНДРИТНЫЕ КЛЕТКИ
https://doi.org/10.15789/1563-0625-2016-4-347-356
Аннотация
Об авторах
Ю. Д. КурочкинаРоссия
аспирант лаборатории клеточной иммунотерапии, врач-ревматолог клиники иммунопатологии,
630099, Novosibirsk, Yadrintsevskaya str., 14,
ct_lab@mail.ru
О. Ю. Леплина
Россия
д.м.н., ведущий научный сотрудник лаборатории клеточной иммунотерапии
М. А. Тихонова
Россия
к.б.н., старший научный сотрудник лаборатории клеточной иммунотерапии
Т. В. Тыринова
Россия
к.м.н., научный сотрудник лаборатории клеточной иммунотерапии
Е. В. Баторов
Россия
к.м.н., научный сотрудник лаборатории клеточной иммунотерапии
А. Э. Сизиков
Россия
к.м.н., заведующий отделением ревматологии Клиники иммунопатологии
А. А. Останин
Россия
д.м.н., профессор, главный научный сотрудник лаборатории клеточной иммунотерапии
Е. Р. Черных
Россия
д.м.н., профессор, член-корр. РАН, заведующая лабораторией клеточной иммунотерапии
Список литературы
1. Bakdash G., Sittig S.P., van Dijk T., Figdor C.G., de Vries I.J. The nature of activatory and tolerogenic dendritic cell-derived signal II. Front Immunol., 2013, Vol. 4, p. 53.
2. Biggioggero M., Gabbriellini L. Meroni P.L. Type I interferon therapy and its role in autoimmunity. Autoimmunity, 2010, Vol. 43, no. 3, pp. 248-254.
3. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFNalpha in systemic lupus erythematosus. Science, 2001, Vol. 294, no. 5546, pp. 1540-1543.
4. Canning M.O., Grotenhuis K., de Wit H.J., Drexhage H.A. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur. J. Endocrinol., 2000, Vol. 143, no. 5, pp. 687-695.
5. Chamorro S. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol., 2009, Vol. 183, no. 5, pp. 2984-2994.
6. Della Bella S., Nicola S., Riva A., Biasin M., Clerici M., Villa M.L. Functional repertoire of dendritic cells generated in granulocyte macrophage-colonystimulating factor and interferon-alpha. J. Leukoc. Biol., 2004, Vol. 75, no. 1, pp. 106-116.
7. Fukada K., Sobao Y., Tomiyama H., Oka S., Takiguchi M. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. J. Immunol., 2002, Vol. 168, no. 5, pp. 2225-2232.
8. García-González P., Morales R., Hoyos L., Maggi J., Campos J., Pesce B., Gárate D., Larrondo M., González R., Soto L., Ramos V., Tobar P., Molina M.C., Pino-Lagos K., Catalán D., Aguillón J.C. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines. J. Transl. Med., 2013, Vol. 11, p. 128.
9. Gauzzi M.C., Maghazachi G., Belardelli F., Adorini L., Jin S.Y., Wang L., Daniel K.C., Maghazachi A.A., Belardelli F., Adorini L., Gessani S. Suppressive effect of 1a,25-Dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J. Immunol., 2005, Vol. 174, no. 1, pp. 270-276.
10. Gessani S., Conti L., Del Cornò M., Belardelli F. Type I interferons as regulators of human antigen presenting cell functions. Toxins (Basel), 2014, Vol. 6, no. 6, pp. 1696-1723.
11. Gordon J.R., Ma Y., Churchman L., Gordon S.A., Dawicki W. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol., 2014, Vol. 5, p. 7.
12. Gottenberg J.E., Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie, 2007, Vol. 89, no. 6-7, pp. 856-871.
13. Harry R.A., Anderson A.E., Isaacs J.D., Hilkens C.M. Generation and characterization of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis., 2010, Vol. 69, no. 11, pp. 2042-2050.
14. Hilkens C.M.U., Isaacs J.D. Tolerogenic dendritic cells in clinical practice. Open Arthritis Journal, 2010, Vol. 3, pp. 8-12.
15. Hubo M., Trinschek B., Kryczanowsky F., Tuettenberg A., Steinbrink K., Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol., 2013, Vol. 4, p. 82.
16. Leplina O.Y., Tyrinova T.V., Tikhonova M.A., Ostanin A.A., Chernykh E.R. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential. Cytokine, 2015, Vol. 71, no. 1, pp. 1-7.
17. Matasic R., Dietz A.B., Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J. Leukoc Biol., 1999, Vol. 66, no. 6, pp. 909-914.
18. Matyszak M.K., Citterio S., Rescigno M., Ricciardi-Castagnoli P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol., 2000, Vol. 30, no. 4, pp. 1233-1242.
19. Paquette R.L., Hsu N.C., Kiertscher S.M., Park A.N., Tran L., Roth M.D., Glaspy J.A. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigenpresenting cells. J. Leukoc. Biol., 1998, Vol. 64, no. 3, pp. 358-367.
20. Peña С., Gárate D., Contreras-Levicoy J., Aravena O., Catalán D., Aguillón J.C. Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharidestimulated collagen-loaded dendritic cells. Clin. Dev. Immunol., 2013, Vol. 2013, Article ID 296031.
21. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V.. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol., 1999, Vol. 162, no. 11, pp. 6473-6481.
22. Rea D., van Kooten C., van Meijgaarden K.E., Melief C.J.M., Offringa R. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen presenting cells that secrete IL-10. Blood, 2000, Vol. 95, no. 10, pp. 3162-3167.
23. Rönnblom L., Eloranta M.L. The interferon signature in autoimmune diseases. Curr Opin Rheumatol., 2013, Vol. 25, no. 2, pp. 248-253.
24. Rozkova D., Horvath R., Bartunkova J., Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite up-regulation of Toll-like receptors. Clin. Immunol., 2006, Vol. 120, no. 3, pp. 260-271.
25. Santini S.M., Lapenta C., Logozzi M., Parlato S., Spada M., di Pucchio T., Belardelli F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in hu-pbl-scid mice. J. Exp. Med., 2000, Vol. 191, no. 10, pp. 1777-1788.
26. Steinman R.M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., Iyoda T., Ravetch J., Dhodapkar M., Inaba K., Nussenzweig M. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci., 2003, Vol. 987, no. 1, pp. 15-25.
27. Syrbe U., Siveke J., Hamann A. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol., 1999, Vol. 21, no. 3, pp. 263-285.
28. Thurner B., Röder C., Dieckmann D., Heuer M., Kruse M., Glaser A., Keikavoussi P., Kämpgen E., Bender A., Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods, 1999, Vol. 223, no. 1, pp. 1-15.
29. Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of T-reg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol., 2009, Vol. 39, no. 11, pp. 3147-3159.
30. Van Kooten C., Stax A.S., Woltman A.M., Gelderman K.A. Handbook of experimental pharmacology “dendritic cells”: the use of dexamethasone in the induction of tolerogenic DCs. Handb. Exp. Pharmacol., 2009, Vol. 188, pp. 233-249.
31. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol., 2000, Vol. 30, no. 7, pp. 1807-1812.
32. Woltman A.M., Vander Kooij S.W., De Fijter J.W., van Kooten C. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+T-cell populations. Am. J. Transplant., 2006, Vol. 6, no. 11, pp. 2580-2591.
33. Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol., 2005, Vol. 62, no. 1, pp. 45-54.
Рецензия
Для цитирования:
Курочкина Ю.Д., Леплина О.Ю., Тихонова М.А., Тыринова Т.В., Баторов Е.В., Сизиков А.Э., Останин А.А., Черных Е.Р. ВЛИЯНИЕ ДЕКСАМЕТАЗОНА НА ИНТЕРФЕРОН-α- ИНДУЦИРОВАННУЮ ДИФФЕРЕНЦИРОВКУ МОНОЦИТОВ В ДЕНДРИТНЫЕ КЛЕТКИ. Медицинская иммунология. 2016;18(4):347-356. https://doi.org/10.15789/1563-0625-2016-4-347-356
For citation:
Kurochkina Yu.D., Leplina O.Yu., Tikhonova M.A., Tyrinova T.V., Batorov E.V., Sizikov A.E., Ostanin A.A., Chernykh E.R. EFFECT OF DEXAMETHASONE ON INTERFERON-α-INDUCED DIFFERENTIATION OF MONOCYTES TO DENDRITIC CELLS. Medical Immunology (Russia). 2016;18(4):347-356. (In Russ.) https://doi.org/10.15789/1563-0625-2016-4-347-356